| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.947 | 95 | 78 | 1991 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.500 | None | 0.981 | 53 | 8 | 1988 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
group | 0.500 | None | 1.000 | 46 | 3 | 2008 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.500 | None | 1.000 | 29 | 4 | 2010 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.931 | 29 | 1 | 1994 | 2019 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.400 | None | 1.000 | 26 | 0 | 1992 | 2020 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 2004 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.500 | None | 1.000 | 19 | 5 | 1999 | 2017 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
group | 0.200 | None | 1.000 | 17 | 3 | 2010 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.400 | None | 0.938 | 16 | 1 | 1994 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.200 | None | 1.000 | 14 | 20 | 2004 | 2018 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.100 | None | 1.000 | 13 | 1 | 1985 | 2019 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 13 | 0 | 2000 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 2005 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 2005 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 1.000 | 12 | 1 | 2005 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1992 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1991 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2004 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1992 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.480 | None | 0.889 | 9 | 2 | 2002 | 2017 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2009 | 2017 | |||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.090 | None | 1.000 | 9 | 1 | 1999 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1991 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1998 | 2018 |